Total Payments
$709,069
2024 Payments
$90,118
Companies
43
Transactions
1,205
Payment Breakdown by Category
Other$571,778 (80.6%)
Travel$102,742 (14.5%)
Food & Beverage$19,983 (2.8%)
Consulting$14,374 (2.0%)
Education$191.97 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $468,463 | 180 | 66.1% |
| Honoraria | $103,316 | 20 | 14.6% |
| Travel and Lodging | $102,742 | 492 | 14.5% |
| Food and Beverage | $19,983 | 497 | 2.8% |
| Consulting Fee | $14,374 | 11 | 2.0% |
| Education | $191.97 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI PASTEUR INC. | $224,002 | 370 | $0 (2024) |
| ParaPRO, LLC | $142,334 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $122,690 | 246 | $0 (2024) |
| Emergent BioSolutions Inc. | $57,854 | 83 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $57,497 | 109 | $0 (2018) |
| Sobi, Inc | $57,373 | 146 | $0 (2021) |
| PFIZER INC. | $43,626 | 52 | $0 (2024) |
| Gilead Sciences, Inc. | $365.82 | 28 | $0 (2019) |
| Theravance Biopharma, Inc. | $300.27 | 11 | $0 (2018) |
| Roche Diagnostics Corporation | $300.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $90,118 | 88 | SANOFI PASTEUR INC. ($46,338) |
| 2023 | $112,135 | 115 | Merck Sharp & Dohme LLC ($52,912) |
| 2022 | $45,477 | 12 | ParaPRO, LLC ($38,606) |
| 2021 | $13,610 | 6 | ParaPRO, LLC ($7,100) |
| 2020 | $53,436 | 77 | SANOFI PASTEUR INC. ($16,821) |
| 2019 | $169,563 | 376 | Emergent BioSolutions Inc. ($57,854) |
| 2018 | $140,533 | 312 | AstraZeneca Pharmaceuticals LP ($54,294) |
| 2017 | $84,198 | 219 | SANOFI PASTEUR INC. ($43,615) |
All Payment Transactions
1,205 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Valneva Usa, Inc. | IXCHIQ (Drug) | Food and Beverage | Cash or cash equivalent | $13.27 | General |
| Category: Vaccine | ||||||
| 11/15/2024 | PFIZER INC. | ABRYSVO (Biological) | Travel and Lodging | In-kind items and services | $480.79 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,166.00 | General |
| Category: Vaccines | ||||||
| 11/13/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Travel and Lodging | Cash or cash equivalent | $324.28 | General |
| Category: Vaccines | ||||||
| 11/13/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Travel and Lodging | Cash or cash equivalent | $260.58 | General |
| Category: Vaccines | ||||||
| 11/13/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Food and Beverage | Cash or cash equivalent | $44.85 | General |
| Category: Vaccines | ||||||
| 11/13/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Travel and Lodging | Cash or cash equivalent | $41.00 | General |
| Category: Vaccines | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | VAXNEUVANCE (Biological) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/07/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,150.00 | General |
| Category: Vaccines | ||||||
| 11/07/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Travel and Lodging | In-kind items and services | $964.01 | General |
| Category: Vaccines | ||||||
| 11/07/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Travel and Lodging | Cash or cash equivalent | $312.79 | General |
| Category: Vaccines | ||||||
| 11/07/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Travel and Lodging | Cash or cash equivalent | $69.00 | General |
| Category: Vaccines | ||||||
| 11/07/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Travel and Lodging | Cash or cash equivalent | $46.57 | General |
| Category: Vaccines | ||||||
| 11/07/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Travel and Lodging | Cash or cash equivalent | $42.48 | General |
| Category: Vaccines | ||||||
| 11/07/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Food and Beverage | Cash or cash equivalent | $31.23 | General |
| Category: Vaccines | ||||||
| 11/06/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,166.00 | General |
| Category: Vaccines | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | VAXNEUVANCE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,590.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/06/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Travel and Lodging | Cash or cash equivalent | $280.42 | General |
| Category: Vaccines | ||||||
| 11/06/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Food and Beverage | Cash or cash equivalent | $73.36 | General |
| Category: Vaccines | ||||||
| 11/06/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
| Category: Vaccines | ||||||
| 10/30/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,166.00 | General |
| Category: Vaccines | ||||||
| 10/30/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Travel and Lodging | Cash or cash equivalent | $408.70 | General |
| Category: Vaccines | ||||||
| 10/30/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Travel and Lodging | Cash or cash equivalent | $168.81 | General |
| Category: Vaccines | ||||||
| 10/30/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Food and Beverage | In-kind items and services | $119.32 | General |
| Category: Vaccines | ||||||
| 10/30/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Food and Beverage | Cash or cash equivalent | $25.54 | General |
| Category: Vaccines | ||||||
About Dr. Christopher Belcher, MD
Dr. Christopher Belcher, MD is a Pediatric Infectious Diseases healthcare provider based in Carmel, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407896392.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Belcher, MD has received a total of $709,069 in payments from pharmaceutical and medical device companies, with $90,118 received in 2024. These payments were reported across 1,205 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($468,463).
Ad
Practice Information
- Specialty Pediatric Infectious Diseases
- Location Carmel, IN
- Active Since 06/07/2006
- Last Updated 10/14/2009
- Taxonomy Code 2080P0208X
- Entity Type Individual
- NPI Number 1407896392
Products in Payments
- Natroba (Drug) $100,053
- VAXNEUVANCE (Biological) $66,895
- FLUZONE HIGH-DOSE (Drug) $62,651
- Vaxchora (Drug) $57,854
- SYNAGIS (Biological) $57,497
- BEYFORTUS (Biological) $44,347
- ABRYSVO (Biological) $40,886
- GARDASIL (Biological) $40,163
- Natroba Topical Suspension, 0.9% (Drug) $34,829
- FLUBLOK QUADRIVALENT (Drug) $34,240
- Synagis (Drug) $33,163
- PENTACEL (Drug) $30,007
- SYNAGIS (Drug) $24,210
- GARDASIL 9 (Biological) $14,520
- FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) $9,345
- FLUZONE HIGH-DOSE (Biological) $8,581
- MENQUADFI (Biological) $7,923
- Natroba Topical Suspension 0.9% (Drug) $7,452
- NO PRODUCT DISCUSSED (Drug) $4,432
- MENACYW CONJUGATE VACCINE (Drug) $3,855
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.